Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement Therapy in Prostate Cancer Survivors With Androgen Deficiency
NCT03716739Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Mar 2019
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone cypionate in androgen deficiency, sponsored by Dana-Farber Cancer Institute. Started Mar 2019; status: completed.
02
Drugs
testosterone cypionate
03
Conditions
androgen deficiency
Beyond the preview
Go deeper on NCT03716739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03716739.